Redhill Biopharma Ltd $ 7.62 -0.21 (-2.68%)
Volume:
342,254
Avg Vol (1m):
736,852
Market Cap $:
353.53 Mil
Enterprise Value $:
404.63 Mil
PE Ratio:
0.00
PB Ratio:
8.70
RDHL News and Headlines - Redhill Biopharma Ltd
GuruFocus Articles
Total 1
- 1
- 1
Titan Pharmaceuticals (OTCBB: TTNP) is a biomedical pharmaceutical company most known for its flagship drug, Probuphine, used to treat opioid addiction. Probuphine has proved to be effective in two clinical studies and one safety study. Titan is in the process of completing one more clinical study before receiving FDA approval, which is expected to be completed by mid-2015.
On January 20, Roth Capital’s Scott Henry released a note launching coverage on Titan Pharmaceuticals with a Buy rating and a $1.25 price target. The analyst gave four driving reasons for the rating:
447 Views TipRanks 2015-01-26 17:07
Headlines
Total 159
- 1
- 2
- 1
- 2
2021-02-19 $ 10.91 (5.92%) | |
10:10am
| |
2021-01-17 | |
2:08pm
| $RDHL - Reassessing RedHill Biopharma. Reassessing Redhill Biopharma - seekingalpha.com |
2021-01-12 $ 7.52 (-13.66%) | |
12:56pm
| Why RedHill Biopharma Stock Is Tanking Today - www.fool.com |
2021-01-07 $ 8.59 (5.01%) | |
8:28am
| RedHill's (RDHL) RHB-204 Gets FDA Fast Track Designation - www.zacks.com |
2021-01-04 $ 8.17 (1.11%) | |
8:41am
| RedHill (RDHL) COVID-19 Drug Shows Promise in Mid-Stage Study - www.zacks.com |
2020-12-28 $ 9.53 (2.25%) | |
10:28am
| |
2020-12-08 $ 8.69 (0.35%) | |
2:30am
| |
2020-12-03 $ 8.63 (-2.15%) | |
1:08pm
| |
2020-11-27 $ 8.85 (3.39%) | |
10:32am
| RedHill (RDHL) Expands Opaganib Manufacturing Capacity in US - www.zacks.com |
2020-11-18 $ 7.9 (-2.47%) | |
11:16am
| RedHill (RDHL) to Begin Study on Second Coronavirus Candidate - www.zacks.com |
2020-11-17 $ 8.1 (0.75%) | |
9:11am
| RedHill (RDHL) Closes Enrollment for Phase II Coronavirus Study - www.zacks.com |
2020-11-13 $ 8.19 (4.87%) | |
7:01am
| RedHill Biopharma to Present at German Equity Forum 2020 - GuruFocus.com |
6:28pm
| |
2020-11-05 $ 8.72 (1.51%) | |
7:02am
| |
2020-11-04 $ 8.59 (4.12%) | |
11:00am
| |
2020-10-31 $ 8.36 (-4.35%) | |
8:12pm
| |
2020-10-26 $ 9.81 (1.34%) | |
11:01am
| |
2020-10-15 $ 10.01 (-0.69%) | |
9:26am
| RedHill's (RDHL) RHB-204 Gets FDA Orphan Drug Designation - www.zacks.com |
2020-10-14 $ 10.08 (-2.98%) | |
11:00am
| |
2020-10-13 $ 10.39 (4.32%) | |
11:01am
| |
2020-10-08 $ 9.71 (1.46%) | |
11:01am
| |
2020-10-07 $ 9.57 (1.27%) | |
11:01am
| |
2020-10-06 $ 9.45 (-8.16%) | |
7:00am
| |
2020-09-23 $ 10.39 (-0.67%) | |
11:46am
| RedHill Gets Nod in Brazil for Coronavirus Study on Opaganib - www.zacks.com |
2020-09-22 $ 10.46 (2.35%) | |
11:00am
| |
2020-09-11 $ 9.95 (-2.07%) | |
3:06pm
| |
7:00am
| $RDHL - RedHill: Possibilities Abound. Redhill Possibilities Abound - seekingalpha.com |
2020-09-09 $ 9.42 (12.01%) | |
7:00am
| |
2020-09-04 $ 7.44 (-5.34%) | |
1:56pm
| |
2020-08-27 $ 7.63 (1.87%) | |
7:00am
| |
2020-08-14 $ 8.37 (-8.92%) | |
8:44pm
| |
2020-08-13 $ 8.37 (-8.92%) | |
6:14pm
| |
7:00am
| |
2020-08-06 $ 7.99 (6.53%) | |
7:01am
| RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico - GuruFocus.com |
2020-08-05 $ 7.5 (1.21%) | |
7:00am
| |
2020-08-03 $ 7.8 (-1.64%) | |
7:00am
| |
2020-07-31 $ 7.93 (5.03%) | |
7:00am
| |
2020-07-30 $ 7.55 (11.36%) | |
7:00am
| RedHill Biopharma Initiates Global Phase 2/3 Study for COVID-19 - GuruFocus.com |
2020-07-28 $ 6.68 (-3.19%) | |
11:01am
| |
2020-07-27 $ 6.9 (1.17%) | |
7:00am
| |
2020-07-22 $ 6.8 (-3%) | |
7:00am
| |
2020-07-21 $ 7.01 (-1.54%) | |
7:00am
| |
2020-07-16 $ 6.7 (2.92%) | |
11:00am
| |
2020-07-09 $ 6.86 (-1.58%) | |
5:06pm
| |
2020-07-01 $ 6.81 (1.64%) | |
7:00am
| |
2020-06-30 $ 6.7 (-4.56%) | |
11:36am
| RedHill (RDHL) to Study Opaganib for Severe Coronavirus in UK - www.zacks.com |
2020-06-29 $ 7.02 (-4.62%) | |
11:00am
| |
2020-06-26 $ 7.36 (3.08%) | |
4:38pm
| |
2020-06-24 $ 6.83 (5.08%) | |
11:01am
| |
2020-06-18 $ 6.64 (-1.78%) | |
3:00pm
| |
11:01am
| |
2020-06-11 $ 7.19 (-6.01%) | |
9:41am
| RedHill Files CTA for Coronavirus Study on Opaganib in Russia - www.zacks.com |
2020-06-10 $ 7.65 (6.55%) | |
7:00am
| |
2020-06-08 $ 7.03 (3.08%) | |
7:00am
| |
2020-06-01 $ 7.09 (-0.42%) | |
11:04am
| RedHill Biopharma to Present at BIO Digital - GuruFocus.com |
2020-05-28 $ 6.95 (-0.71%) | |
7:00am
| |
2020-05-27 $ 7 (-2.51%) | |
2:45pm
| |
2020-05-21 $ 7.09 (-2.34%) | |
3:17pm
| |
2020-05-20 $ 7.26 (1.54%) | |
7:00am
| |
2020-05-15 $ 6.72 (-1.03%) | |
10:30am
| |
2020-05-11 $ 7.24 (4.93%) | |
7:02am
| |
2020-05-10 | |
7:44am
| |
2020-05-08 $ 6.9 (5.5%) | |
7:00am
| |
2020-05-05 $ 6.64 (-2.92%) | |
7:00am
| |
2020-04-28 $ 7.66 (-10.93%) | |
10:30am
| |
7:00am
| |
2020-04-27 $ 8.6 (13.16%) | |
1:20pm
| Why RedHill Biopharma Is Trouncing the Market Today - www.fool.com |
7:00am
| |
2020-04-21 $ 6.83 (-4.61%) | |
11:19am
| RedHill's Oncology Candidate to be Tested for Coronavirus - www.zacks.com |
2020-04-20 $ 7.16 (13.11%) | |
11:00am
| |
2020-04-17 $ 6.33 (-10.97%) | |
3:00pm
| |
11:00am
| |
2020-04-15 $ 7.46 (-0.67%) | |
7:44am
| RedHill (RDHL) Soars: Stock Adds 9.2% in Session - www.zacks.com |
2020-04-13 $ 6.88 (13.72%) | |
7:00am
| |
2020-04-09 $ 6.05 (-1.79%) | |
9:02am
| Top Ranked Momentum Stocks to Buy for April 9th - www.zacks.com |
2020-04-07 $ 6.1 (8.93%) | |
8:25am
| Top Ranked Momentum Stocks to Buy for April 7th - www.zacks.com |
2020-04-06 $ 5.6 (17.65%) | |
7:02am
| |
7:01am
| |
2020-04-03 $ 4.76 (-8.11%) | |
10:32am
| Will RedHill Biopharma Continue to Surge Higher? - www.zacks.com |
2020-04-02 $ 5.18 (12.61%) | |
7:00am
| |
2020-03-25 $ 4.28 (0.23%) | |
7:00am
| RedHill Biopharma Provides Business Update - GuruFocus.com |
2020-03-13 $ 4.35 (23.93%) | |
7:00am
| |
2020-03-11 $ 3.99 (-8.28%) | |
7:00am
| RedHill Biopharma Provides Update on Opaganib (Yeliva®) - GuruFocus.com |
2020-03-10 $ 4.35 (3.08%) | |
7:00am
| |
2020-03-09 $ 4.22 (-10.4%) | |
7:00am
| |
2020-02-27 $ 4.05 (-13.65%) | |
7:01am
| |
2020-02-25 $ 4.52 (-3.83%) | |
3:00am
| |
3:00am
| RedHill Biopharma Acquires Rights to Movantik® from AstraZeneca - GuruFocus.com |
2020-02-18 $ 4.94 (-1.2%) | |
7:00am
| |
2020-01-27 $ 5.88 (-1.34%) | |
7:00am
| |
2020-01-21 $ 6.01 (-1.96%) | |
7:00am
| |
2020-01-02 $ 6.06 (-0.16%) | |
11:00am
| |
2019-12-17 $ 5.92 (-2.15%) | |
11:00am
| |
2019-11-15 $ 6.25 (1.63%) | |
7:00am
| |
2019-11-13 $ 6.23 (2.13%) | |
7:00am
| |
2019-11-12 $ 6.1 (-4.39%) | |
7:00am
| |
2019-11-04 $ 7.35 (6.21%) | |
7:01am
| |
2019-10-29 $ 6.7 (1.67%) | |
11:01am
| RedHill Biopharma to Present at the BIO-Europe 2019 Conference - GuruFocus.com |
2019-10-28 $ 6.59 (4.6%) | |
11:02am
| |
2019-10-18 $ 6.35 (2.92%) | |
7:00am
|
- 1
- 2